返回
SinoMab BioScience Limited（03681.HK）价格
03681.HK 股价走势图
SINOMAB BIO-B (03681.HK)
SinoMab BioScience Limited
HK$1.44
-6.49%
$-0.1
休市： Jan 16, 16:00:00 HKT
关键数据
前收盘价
$1.54
开盘价
$1.54
当日区间
$1.44 - $1.54
52周范围
$0.8 - $3.76
交易量
4.2M
平均成交量
5.9M
每股收益（TTM）
-0.16
股息收益率
--
市值
$1.9B
什么是 SINOMAB BIO-B？
SinoMab Bioscience Ltd. is a clinical stage biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody-based biologics. The company employs 61 full-time employees The company went IPO on 2019-11-12. The firm primarily develops mAb-based biologics and new chemical entities (NCE) and its product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The firm is also developing drugs such as SM17, which has the potential to treat atopic dermatitis (AD), asthma, idiopathic pulmonary fibrosis (IPF) and other immune diseases, and SN1011, which targets systemic lupus erythematosus (SLE), pemphigus, multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD).
